These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 9826622)

  • 1. Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy.
    Roopnarine O; Leinwand LA
    Biophys J; 1998 Dec; 75(6):3023-30. PubMed ID: 9826622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy.
    Cuda G; Fananapazir L; Epstein ND; Sellers JR
    J Muscle Res Cell Motil; 1997 Jun; 18(3):275-83. PubMed ID: 9172070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome.
    Sata M; Ikebe M
    J Clin Invest; 1996 Dec; 98(12):2866-73. PubMed ID: 8981935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. Molecular force level of mutant myosins may have a prognostic implication.
    Fujita H; Sugiura S; Momomura S; Omata M; Sugi H; Sutoh K
    J Clin Invest; 1997 Mar; 99(5):1010-5. PubMed ID: 9062359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional consequences of mutations in the smooth muscle myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy.
    Yamashita H; Tyska MJ; Warshaw DM; Lowey S; Trybus KM
    J Biol Chem; 2000 Sep; 275(36):28045-52. PubMed ID: 10882745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myosin motor domains carrying mutations implicated in early or late onset hypertrophic cardiomyopathy have similar properties.
    Vera CD; Johnson CA; Walklate J; Adhikari A; Svicevic M; Mijailovich SM; Combs AC; Langer SJ; Ruppel KM; Spudich JA; Geeves MA; Leinwand LA
    J Biol Chem; 2019 Nov; 294(46):17451-17462. PubMed ID: 31582565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy.
    Rayment I; Holden HM; Sellers JR; Fananapazir L; Epstein ND
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3864-8. PubMed ID: 7731997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.
    Eldin P; Le Cunff M; Mornet D; Leger JJ
    Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):345-51. PubMed ID: 7887887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-Onset Hypertrophic Cardiomyopathy Mutations Significantly Increase the Velocity, Force, and Actin-Activated ATPase Activity of Human β-Cardiac Myosin.
    Adhikari AS; Kooiker KB; Sarkar SS; Liu C; Bernstein D; Spudich JA; Ruppel KM
    Cell Rep; 2016 Dec; 17(11):2857-2864. PubMed ID: 27974200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties.
    Keller DI; Coirault C; Rau T; Cheav T; Weyand M; Amann K; Lecarpentier Y; Richard P; Eschenhagen T; Carrier L
    J Mol Cell Cardiol; 2004 Mar; 36(3):355-62. PubMed ID: 15010274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point mutations in human beta cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: an ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly.
    Becker KD; Gottshall KR; Hickey R; Perriard JC; Chien KR
    J Cell Biol; 1997 Apr; 137(1):131-40. PubMed ID: 9105042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
    Ramírez CD; Padrón R
    Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Failure to Communicate: MYOSIN RESIDUES INVOLVED IN HYPERTROPHIC CARDIOMYOPATHY AFFECT INTER-DOMAIN INTERACTION.
    Kronert WA; Melkani GC; Melkani A; Bernstein SI
    J Biol Chem; 2015 Dec; 290(49):29270-80. PubMed ID: 26446785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac and skeletal muscle expression of mutant β-myosin heavy chains, degree of functional impairment and phenotypic heterogeneity in hypertrophic cardiomyopathy.
    Di Domenico M; Casadonte R; Ricci P; Santini M; Frati G; Rizzo A; Carratelli CR; Lamberti M; Parrotta E; Quaresima B; Faniello CM; Costanzo F; Cuda G
    J Cell Physiol; 2012 Oct; 227(10):3471-6. PubMed ID: 22213221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypertrophic cardiomyopathy mutations R403Q and R663H increase the number of myosin heads available to interact with actin.
    Sarkar SS; Trivedi DV; Morck MM; Adhikari AS; Pasha SN; Ruppel KM; Spudich JA
    Sci Adv; 2020 Apr; 6(14):eaax0069. PubMed ID: 32284968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac contractile proteins].
    Sugiura S; Sata M; Serizawa T
    Nihon Rinsho; 1993 May; 51(5):1146-50. PubMed ID: 8331781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myosin mutations in hypertrophic cardiomyopathy and functional implications.
    Vosberg HP
    Herz; 1994 Apr; 19(2):75-83. PubMed ID: 8194835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hypertrophic cardiomyopathy associated with a novel missense mutation affecting the ATP-binding region of the cardiac beta-myosin heavy chain.
    Bundgaard H; Havndrup O; Andersen PS; Larsen LA; Brandt NJ; Vuust J; Kjeldsen K; Christiansen M
    J Mol Cell Cardiol; 1999 Apr; 31(4):745-50. PubMed ID: 10329202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function studies of the myosin motor domain: importance of the 50-kDa cleft.
    Ruppel KM; Spudich JA
    Mol Biol Cell; 1996 Jul; 7(7):1123-36. PubMed ID: 8862525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.
    Flavigny J; Souchet M; Sébillon P; Berrebi-Bertrand I; Hainque B; Mallet A; Bril A; Schwartz K; Carrier L
    J Mol Biol; 1999 Nov; 294(2):443-56. PubMed ID: 10610770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.